Isolated limb perfusion in the management of in-transit melanoma metastases: A monoistitutional experience

被引：0
|
作者：
Patuzzo, R. [1 ]
Ruggeri, R. [1 ]
Gallino, G. [1 ]
Maurichi, A. [1 ]
Mattavelli, I. [1 ]
Baffa, G. [1 ]
Tinti, M. C. [1 ]
Castelli, G. P. [2 ]
Santinami, M. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] Osped Siracusa, Siracusa, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3730
引用
收藏
页码：S865 / S865
页数：1
相关论文
共 50 条
  • [1] Management of in-transit melanoma of the extremity with isolated limb perfusion
    Fraker D.L.
    Current Treatment Options in Oncology, 2004, 5 (3) : 173 - 184
  • [2] Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases
    Deroose, Jan P.
    Grunhagen, Dirk J.
    Eggermont, Alexander M. M.
    Verhoef, Cornelis
    MELANOMA RESEARCH, 2015, 25 (05) : 427 - 431
  • [3] Isolated Limb Perfusion for In-Transit Melanoma Metastases: Melphalan or TNF-Melphalan Perfusion?
    Hoekstra, Harald J.
    Veerman, Kelly
    Van Ginkel, Robert J.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (04) : 338 - 347
  • [4] Isolated Limb Perfusion and Immunotherapy in the Treatment of In-Transit Melanoma Metastases: Is It a Real Synergy?
    Rastrelli, Marco
    Russano, Francesco
    Cavallin, Francesco
    Del Fiore, Paolo
    Pacilli, Claudia
    Di Prata, Claudia
    Rossi, Carlo Riccardo
    Vecchiato, Antonella
    Dall'Olmo, Luigi
    Mocellin, Simone
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (05):
  • [5] Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment
    Bhutta, Muhammad Eeman
    Siddique, Muhammad Hammad
    Siddique, Zainab
    EJSO, 2024, 50 (12):
  • [6] Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases
    Carl-Jacob, Holmberg
    Mattsson, Jan
    Bagge, Roger Olofsson
    CANCERS, 2023, 15 (02)
  • [7] Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment
    Holmberg, Carl-Jacob
    Zijlker, Lisanne P.
    Katsarelias, Dimitrios
    Huibers, Anne E.
    Wouters, Michel W. J. M.
    Schrage, Yvonne
    Reijers, Sophie J. M.
    van Thienen, Johannes V.
    Grunhagen, Dirk J.
    Martner, Anna
    Nilsson, Jonas A.
    van Akkooi, Alexander C. J.
    Ny, Lars
    van Houdt, Winan J.
    Bagge, Roger Olofsson
    EJSO, 2024, 50 (12):
  • [8] One hundred fifty six isolated limb perfusion (ILP) in melanoma patients with in-transit metastases
    Cavalcanti, A.
    Souadka, A.
    Israel, P.
    Mateus, C.
    Robert, C.
    Bonvalot, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 57 - 57
  • [9] 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
    Jan P. Deroose
    Alexander M. M. Eggermont
    Albertus N. van Geel
    Johannes H. W. de Wilt
    Jacobus W. A. Burger
    Cornelis Verhoef
    Annals of Surgical Oncology, 2012, 19 : 627 - 635
  • [10] 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
    Deroose, Jan P.
    Eggermont, Alexander M. M.
    van Geel, Albertus N.
    de Wilt, Johannes H. W.
    Burger, Jacobus W. A.
    Verhoef, Cornelis
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) : 627 - 635
12345